CEO Paywatch: Hormel CEO's pay fell slightly after it missed a profit goal

James Snee's realized compensation dipped 2.3% in the company's fiscal year that ended in October.

December 28, 2022 at 12:20AM
James Snee, chair, president and CEO of Hormel Foods (File photo/The Minnesota Star Tribune)

James Snee

Hormel Foods Corp.

Chair, chief executive and president

  • Total compensation: $7,489,188 for the year ended Oct. 31
    • Salary: $1,000,000
      • Nonequity incentive pay: $4,734,050
        • Other compensation: $244,278
          • Exercised stock options: $1,510,860
            • New stock options: 209,800
              • Median employee pay: $50,369
                • CEO pay ratio: 188 to 1
                  • Total fiscal 2021 total return: 13.4%

                    Note: Snee's compensation decreased from $7.7 million to $7.5 million owing to a small decrease in his annual cash incentive pay and a $100,000 reduction in the value of previously issued stock options that he exercised this year in comparison to last year.

                    Hormel's annual cash incentive combines an Operators' Share Plan (a plan that has been in place since 1932) based on earnings per share performance and an Annual Incentive Plan (AIP) based on a mix of financial measures.

                    In fiscal 2022 Hormel fell short of the goals for both the Operators' Share Plan and the AIP, resulting in lower-than-target payouts.

                    Hormel's stock had a total return of 13.4% over the 12 months of its fiscal year ended Oct. 31. That made it a rare gainer over a period when the S&P 500 Index had a negative 14% return.

                    At Hormel, 10% of Snee's AIP compensation can be earned by achieving inclusion and diversity targets. While those goals were not specifically defined in the proxy statement, the company did say Hormel underperformed on the environmental, social and governance goals last year.

                    about the writer

                    about the writer

                    Patrick Kennedy

                    Reporter

                    Business reporter Patrick Kennedy covers executive compensation and public companies. He has reported on the Minnesota business community for more than 25 years.

                    See Moreicon

                    More from Business

                    See More
                    card image
                    Provided by Exact Sciences

                    The late Dr. David Ahlquist co-invented ColoGuard, which is helping drive Abbott Laboratories’ acquisition of Exact Sciences. After an ALS diagnosis in 2019, Ahlquist wasn’t done inventing.

                    card image
                    card image